The paired analysis of primary tumor and metastases showed the existence of discrepancies in BRAF/NRAS mutation patterns: interestingly, the highest frequency of these discrepancies was observed in patients with cerebral and subcutaneous metastases [18]; in half of the discrepant cases, a wild-type primary tumor and a mutated metastasis was observed. This evidence concerns the gene BRAF and neoplasm.